PreciControl HIV; HIV-2+GrpO - HIV1/HIV2 antigen/antibody IVD, control

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Disponible depuis:

Roche Diagnostics Australia Pty Limited

classe:

Class 4

Fabriqué par:

Roche Diagnostics GmbH Sandhofer Strasse 116, Mannheim, D-68305 Germany

Domaine thérapeutique:

48449 - HIV1/HIV2 antigen/antibody IVD, control

indications thérapeutiques:

PreciControl HIV; HIV-2+GrpO is a lyophilized control serum based on human serum. The controls are used for monitoring the accuracy of the Elecsys HIV combi PT and Elecsys HIV Duo assays. PreciControl HIV; HIV-2GrpO is used for quality control of the Elecsys HIV combi PT and Elecsys HIV Duo immunoassays on the Elecsys and cobas e immunoassay analysers

Statut de autorisation:

A

Date de l'autorisation:

2018-05-18